Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Novel CAR T Modules (Tmod) to Target HLA-Class I Loss in Lymphoma

Agnes E. Hamburger, PhD, Breanna DiAndreth, PhD, Mark E. Daris, BS, Melanie L. Munguia, BS, Kiran Deshmukh, MS, Jee-Young Mock, PhD, Grace E. Asuelime, MS, Emily D. Lim, BS, Michelle R. Kreke, PhD, Talar Tokatlian, PhD, David Maloney, MD PhD, William Y. Go, MDPhD, Alexander Kamb, PhD

Blood (2020) 136 (Supplement 1): 23–24.

https://doi.org/10.1182/blood-2020-134041

Published: 2020

Journal Articles

Primary Analysis of Zuma-5: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory (R/R) Indolent Non-Hodgkin Lymphoma (iNHL)

Blood (2020) 136 (Supplement 1): 40–41.

https://doi.org/10.1182/blood-2020-136834

Published: 2020

Journal Articles

Evaluation of Two Structurally Distinct Novel Inhibitors of Apoptosis Signal-Regulating Kinase 1 (MAP3K5), As Potent Anti-Platelet Agents

Meghna U. Naik, M.Sc., Xi Chen, PhD, Brendan Bachman, M S, Ganesha Rai, PhD, David Maloney, PhD, Arjit Jadhav, PhD, Ulhas P. Naik, PhD FAHA

Blood (2016) 128 (22): 3833.

https://doi.org/10.1182/blood.V128.22.3833.3833

Published: 2016

Journal Articles

Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus

Blood (2014) 124 (9): 1404–1411.

https://doi.org/10.1182/blood-2014-03-565135

Published: 2014

Journal Articles

Nonmyeloablative allografting for newly diagnosed multiple myeloma: the experience of the Gruppo Italiano Trapianti di Midollo

Blood (2009) 113 (14): 3375–3382.

https://doi.org/10.1182/blood-2008-07-167379

Published: 2009

Journal Articles

Low-Dose Total Body Irradiation (TBI) and Fludarabine Conditioning for Hematopoietic Cell Transplantation (HCT) in Patients with HLA-Class I Mismatched Donors.

Hirohisa Nakamae, Barry Storer, Thomas Chauncey, Michael Pulsipher, Finn Petersen, James C. Wade, Michael Maris, Ben Bruno, Effie Petersdorf, David Maloney, Rainer Storb, Brenda M. Sandmaier

Blood (2007) 110 (11): 3067.

https://doi.org/10.1182/blood.V110.11.3067.3067

Published: 2007

Journal Articles

A Large Cohort Analysis of CMV Viral Load and Ganciclovir-Related Neutropenia in Nonmyeloablative (NM-HCT) and Myeloablative (M-HCT) Allogeneic Hematopoietic Cell Transplant Recipients.

Hirohisa Nakamae, MD, Katharine A. Kirby, MS, Brenda M. Sandmaier, MD, Lalita Norasetthada, MD, David Maloney, MD, Michael Maris, MD, Chris Davis, MD, Lawrence Corey, MD, Rainer Storb, MD, Michael Boeckh, MD

Blood (2007) 110 (11): 2975.

https://doi.org/10.1182/blood.V110.11.2975.2975

Published: 2007

Journal Articles

Reversal of Low Chimerism Following Nonmyeloablative (NM) Hematopoietic Cell Transplantation (HCT) Using Pentostatin and Donor Lymphocyte Infusions (DLI).

Monica Thakar, MD, Barry Storer, PhD, Thomas Chauncey, MD, PhD, Michael Pulsipher, MD, David Maloney, MD, PhD, Rainer Storb, MD, Brenda Sandmaier, MD

Blood (2007) 110 (11): 480.

https://doi.org/10.1182/blood.V110.11.480.480

Published: 2007

Journal Articles

An Update of a Phase II Trial of CHOP Followed by Tositumomab/Iodine I-131 Tositumomab (Bexxar®) for Front-Line Treatment of Advanced Stage, Follicular Lymphoma: Southwest Oncology Group Protocol 9911.

Oliver W. Press, MD, PhD, Joseph Unger, David Maloney, MD, PhD, Rita M. Braziel, MD, Michael LeBlanc, PhD, Thomas Grogan, MD, Thomas P. Miller, MD, Richard I. Fisher, MD

Blood (2005) 106 (11): 352.

https://doi.org/10.1182/blood.V106.11.352.352

Published: 2005

Journal Articles

Nonmyeloablative and Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies: Outcomes with HLA-Matched Unrelated Donors Compared to HLA-Identical Sibling Donors.

Marco Mielcarek, MD, Barry Storer, PhD, Christoph Kahl, MD, Brenda M. Sandmaier, MD, David Maloney, MD, PhD, Mike B. Maris, MD, Rainer Storb, MD

Blood (2005) 106 (11): 658.

https://doi.org/10.1182/blood.V106.11.658.658

Published: 2005

Journal Articles

Relapse Risk after Nonmyeloablative Hematopoietic Cell Transplantation for Malignant Diseases.

Christoph Kahl, MD, Barry Storer, PhD, Marco Mielcarek, MD, Mike Maris, MD, Brenda Sandmaier, MD, David Maloney, MD, PhD, Thomas Chauncey, MD, Dietger Niederwieser, MD, Peter McSweeney, MD, Benedetto Bruno, MD, Karl Blume, MD, James Wade, MD, Jose Leis, MD, PhD, Emilia Langston, MD, Michael Pulsipher, MD, Edward Agura, MD, Rainer Storb, MD

Blood (2005) 106 (11): 703.

https://doi.org/10.1182/blood.V106.11.703.703

Published: 2005

Journal Articles

Relationship between Conditioning Intensity and Comorbidity in Patients (Pts) with Acute Myeloid Leukemia (AML) or Myelodysplasia (MDS) Receiving Allogeneic Hematopoietic Cell Transplantation (HCT).

Mohamed Sorror, MD, MSc, Barry Storer, PhD, Brenda M. Sandmaier, MD, Michael Maris, MD, Frederic Baron, MD, PhD, David Maloney, MD, PhD, Bart Scott, MD, H. Joachim Deeg, MD, Rainert Storb, MD

Blood (2005) 106 (11): 705.

https://doi.org/10.1182/blood.V106.11.705.705

Published: 2005

Journal Articles

Nonmyeloablative Conditioning and Hematopoietic Cell Transplantation (HCT) from HLA-Matched Related or Unrelated Donors for Chemotherapy-Refractory Chronic Lymphocytic Leukemia (CLL).

Mohamed Sorror, MD, MSc, Michael Maris, MD, Barry Storer, PhD, Brenda Sandmaier, MD, Monic Stuart, MD, Ute Hegenbart, MD, Edward Agura, MD, Thomas Chauncey, MD, Jose Leis, MD, PhD, Michael Pulsipher, MD, Peter McSweeney, MD, Jerry Radich, MD, James Wade, MD, Benedetto Bruno, MD, Amelia Langston, MD, Dietger Niederwieser, MD, Karl Blume, MD, Rainer Storb, MD, David Maloney, MD, PhD

Blood (2004) 104 (11): 2323.

https://doi.org/10.1182/blood.V104.11.2323.2323

Published: 2004

Journal Articles

Higher Doses of Transplanted CD34+, CD3+ and CD8+ Cells Are Associated with Better Donor T-Cell Chimerism and Less Graft Rejection, but Not with GVHD after Nonmyeloablative Conditioning for Unrelated Hematopoietic Cell Transplantation.

Frederic Baron, Michael Maris, Barry Storer, Brenda Sandmaier, Jens Panse, Thomas Chauncey, Mohamed Sorror, Marie Terese Little, David Maloney, Rainer Storb, Shelly Heimfeld

Blood (2004) 104 (11): 2753.

https://doi.org/10.1182/blood.V104.11.2753.2753

Published: 2004

Journal Articles

Treatment for Acute Myelogenous Leukemia by Low Dose Irradiation Based Conditioning and Hematopoietic Cell Transplantation from Related and Unrelated Donors.

Dietger W. Niederwieser, Ute Hegenbart, MD, Brenda M. Sandmaier, MD, Michael B. Maris, MD, Monic Stuart, MD, Hildegard Greinix, MD, Catherine Cordonnier, Bernard Rio, MD, Alois Gratwohl, Thoralf Lange, MD, Wolfram Pönisch, MD, Leante Grommisch, MD, Barry Storer, MD, David Maloney, MD, Peter McSweeney, MD, Thomas Chauncey, MD, Ed Agura, MD, Karl Blume, Rainer Storb

Blood (2004) 104 (11): 3074.

https://doi.org/10.1182/blood.V104.11.3074.3074

Published: 2004

Journal Articles

A Modified Hematopoietic Cell Transplantation (HCT)-Specific-Comorbidity Index.

Mohamed Sorror, MD, MSc, Maris Maris, MD, Frederic Baron, MD, Brenda Sandmaier, MD, David Maloney, MD, PhD, Rainer Storb, MD, Barry Storer, PhD

Blood (2004) 104 (11): 1146.

https://doi.org/10.1182/blood.V104.11.1146.1146

Published: 2004

Journal Articles

Prognostic Relevance of “Early-Onset” Graft-Versus-Host Disease Following Nonmyeloablative Hematopoietic Cell Transplantation.

Marco Mielcarek, MD, Lauri Burroughs, MD, Wendy Leisenring, PhD, Paul Martin, MD, Razvan Diaconezcu, MD, Brenda Sandmaier, MD, David Maloney, MD, PhD, Thomas Chauncey, MD, PhD, Michael Maris, MD, Judith Shizuru, MD, Karl Blume, MD, Ute Hegenbart, MD, Dietger Niederwieser, MD, Stephen Forman, MD, Benedetto Bruno, MD, Ann Woolfrey, MD, Rainer Storb, MD

Blood (2004) 104 (11): 423.

https://doi.org/10.1182/blood.V104.11.423.423

Published: 2004

Journal Articles

166 Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: results of two phase 1/2 trials

Sergio Giralt, William Bensinger, Mark Goodman, Donald Podoloff, Janet Eary, Richard Wendt, Raymond Alexanian, Donna Weber, David Maloney, Leona Holmberg, Joseph Rajandran, Hazel Breitz, Richard Ghalie, Richard Champlin

Blood (2003) 102 (7): 2684–2691.

https://doi.org/10.1182/blood-2002-10-3250

Published: 2003

Journal Articles

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

Michael B. Maris, Dietger Niederwieser, Brenda M. Sandmaier, Barry Storer, Monic Stuart, David Maloney, Effie Petersdorf, Peter McSweeney, Michael Pulsipher, Ann Woolfrey, Thomas Chauncey, Ed Agura, Shelly Heimfeld, John Slattery, Ute Hegenbart, Claudio Anasetti, Karl Blume, Rainer Storb

Blood (2003) 102 (6): 2021–2030.

https://doi.org/10.1182/blood-2003-02-0482

Published: 2003

NARROW

Novel CAR T Modules (Tmod) to Target HLA-Class I Loss in Lymphoma

Primary Analysis of Zuma-5: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory (R/R) Indolent Non-Hodgkin Lymphoma (iNHL)

Evaluation of Two Structurally Distinct Novel Inhibitors of Apoptosis Signal-Regulating Kinase 1 (MAP3K5), As Potent Anti-Platelet Agents

Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus

Nonmyeloablative allografting for newly diagnosed multiple myeloma: the experience of the Gruppo Italiano Trapianti di Midollo

Low-Dose Total Body Irradiation (TBI) and Fludarabine Conditioning for Hematopoietic Cell Transplantation (HCT) in Patients with HLA-Class I Mismatched Donors.

A Large Cohort Analysis of CMV Viral Load and Ganciclovir-Related Neutropenia in Nonmyeloablative (NM-HCT) and Myeloablative (M-HCT) Allogeneic Hematopoietic Cell Transplant Recipients.

Reversal of Low Chimerism Following Nonmyeloablative (NM) Hematopoietic Cell Transplantation (HCT) Using Pentostatin and Donor Lymphocyte Infusions (DLI).

An Update of a Phase II Trial of CHOP Followed by Tositumomab/Iodine I-131 Tositumomab (Bexxar®) for Front-Line Treatment of Advanced Stage, Follicular Lymphoma: Southwest Oncology Group Protocol 9911.

Nonmyeloablative and Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies: Outcomes with HLA-Matched Unrelated Donors Compared to HLA-Identical Sibling Donors.

Relapse Risk after Nonmyeloablative Hematopoietic Cell Transplantation for Malignant Diseases.

Relationship between Conditioning Intensity and Comorbidity in Patients (Pts) with Acute Myeloid Leukemia (AML) or Myelodysplasia (MDS) Receiving Allogeneic Hematopoietic Cell Transplantation (HCT).

Nonmyeloablative Conditioning and Hematopoietic Cell Transplantation (HCT) from HLA-Matched Related or Unrelated Donors for Chemotherapy-Refractory Chronic Lymphocytic Leukemia (CLL).

Higher Doses of Transplanted CD34+, CD3+ and CD8+ Cells Are Associated with Better Donor T-Cell Chimerism and Less Graft Rejection, but Not with GVHD after Nonmyeloablative Conditioning for Unrelated Hematopoietic Cell Transplantation.

Treatment for Acute Myelogenous Leukemia by Low Dose Irradiation Based Conditioning and Hematopoietic Cell Transplantation from Related and Unrelated Donors.

A Modified Hematopoietic Cell Transplantation (HCT)-Specific-Comorbidity Index.

Prognostic Relevance of “Early-Onset” Graft-Versus-Host Disease Following Nonmyeloablative Hematopoietic Cell Transplantation.

166 Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: results of two phase 1/2 trials

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only